I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 35% ± 22% | |
| GABAergic neuron | 4 studies | 39% ± 19% | |
| neuron | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 5 studies | 35% ± 22% | |
| GABAergic neuron | 4 studies | 39% ± 19% | |
| neuron | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 32% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 8189.41 | 653 / 653 | 98% | 24.75 | 594 / 605 |
| brain | 98% | 9969.39 | 2600 / 2642 | 99% | 23.24 | 697 / 705 |
| prostate | 100% | 6279.42 | 244 / 245 | 96% | 10.06 | 480 / 502 |
| adrenal gland | 99% | 3508.02 | 256 / 258 | 91% | 50.56 | 210 / 230 |
| kidney | 89% | 2162.48 | 79 / 89 | 81% | 6.26 | 729 / 901 |
| breast | 95% | 3121.97 | 436 / 459 | 63% | 3.37 | 707 / 1118 |
| uterus | 99% | 9077.40 | 169 / 170 | 39% | 3.28 | 178 / 459 |
| bladder | 95% | 5423.48 | 20 / 21 | 38% | 1.84 | 192 / 504 |
| lung | 79% | 1921.69 | 457 / 578 | 52% | 2.50 | 605 / 1155 |
| ovary | 100% | 14803.08 | 180 / 180 | 24% | 0.88 | 102 / 430 |
| intestine | 90% | 4934.30 | 866 / 966 | 29% | 1.67 | 154 / 527 |
| pancreas | 28% | 451.79 | 92 / 328 | 90% | 9.86 | 161 / 178 |
| spleen | 99% | 3286.69 | 239 / 241 | 0% | 0 | 0 / 0 |
| skin | 47% | 824.24 | 844 / 1809 | 52% | 3.30 | 247 / 472 |
| blood vessel | 99% | 4326.71 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 71% | 2881.96 | 1032 / 1445 | 27% | 1.18 | 49 / 183 |
| stomach | 53% | 2195.39 | 189 / 359 | 39% | 2.00 | 111 / 286 |
| eye | 0% | 0 | 0 / 0 | 90% | 6.93 | 72 / 80 |
| adipose | 87% | 2303.36 | 1043 / 1204 | 0% | 0 | 0 / 0 |
| heart | 78% | 2389.86 | 672 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 2.76 | 16 / 29 |
| muscle | 22% | 335.41 | 178 / 803 | 0% | 0 | 0 / 0 |
| liver | 2% | 21.75 | 4 / 226 | 14% | 0.67 | 58 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.32 | 5 / 45 |
| peripheral blood | 4% | 51.51 | 33 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008333 | Biological process | endosome to lysosome transport |
| GO_1990172 | Biological process | G protein-coupled receptor catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GPRASP1 |
| Protein name | G-protein coupled receptor-associated sorting protein 1 (GASP-1) |
| Synonyms | GASP KIAA0443 |
| Description | FUNCTION: Modulates lysosomal sorting and functional down-regulation of a variety of G-protein coupled receptors. Targets receptors for degradation in lysosomes via its interaction with BECN2. . |
| Accessions | ENST00000444152.5 Q5JY77 ENST00000537097.2 ENST00000361600.9 ENST00000415986.5 ENST00000652542.1 |
